AWH Aspira Womens Health Inc.

Aspira engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  07/12/2006
Outstanding shares:  112,126,549
Average volume:  1,850,825
Market cap:   $225,374,363
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04537Y109
ISIN:        US04537Y1091
Valuation   (See tab for details)
PE ratio:   -7.99
PB ratio:   5.98
PS ratio:   35.18
Return on equity:   -74.75%
Net income %:   -449.23%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy